ezetimibe has been researched along with Atrial Fibrillation in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, W; Wang, CX; Wu, QH; Yang, PP; Yang, S; Zhang, HZ | 1 |
| Hu, WS; Lin, CL; Yu, TS | 1 |
| Azarpazhooh, MR; Bogiatzi, C; Hankey, GJ; Larsson, SC; Spence, JD | 1 |
| Bang, CN; Dalsgaard, M; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Ray, S; Rossebø, AB; Wachtell, K | 1 |
| Lappegård, KT; Pop, G; Pop-Purceleanu, M; Sexton, J; Tendolkar, I; van Heerde, W | 1 |
| Bang, CN; Berg, RM; Boman, K; Devereux, RB; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Nielsen, OW; Nienaber, CA; Okin, PM; Ray, S; Rossebø, AB; Wachtell, K | 1 |
| Bouwels, L; de Leeuw, FE; Enajat, M; Pop, G; Pop-Purceleanu, M; Tendolkar, I; van Kuilenburg, J; van Wingen, G; Zwiers, MP | 1 |
| Bang, CN; Boman, K; Egstrup, K; Gohlke-Baerwolf, C; Greve, AM; Køber, L; Nienaber, CA; Ray, S; Rossebø, AB; Wachtell, K | 1 |
| Leung, AA; van Walraven, C | 1 |
3 review(s) available for ezetimibe and Atrial Fibrillation
| Article | Year |
|---|---|
Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials.
Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Atrial Fibrillation; Cardiovascular Diseases; Ezetimibe; Heart Disease Risk Factors; Humans; Proprotein Convertase 9; Randomized Controlled Trials as Topic; Risk Factors | 2023 |
Stroke Prevention in Older Adults: Recent Advances.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carotid Stenosis; Dementia; Diet; Diet, Vegetarian; Endarterectomy, Carotid; Ezetimibe; Factor Xa Inhibitors; Gastrointestinal Microbiome; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Patient Care Planning; Patient Selection; Platelet Aggregation Inhibitors; Renal Insufficiency; Stents; Stroke; Vascular Stiffness; Vitamin B Complex | 2020 |
Reviewing the medical literature: five notable articles in general internal medicine from 2010 and 2011.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Atrial Fibrillation; Azetidines; Cardiomyopathies; Ezetimibe; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pyrazoles; Pyridones; Recurrence; Risk; Seizures; Simvastatin; Ultrasonography; Warfarin | 2012 |
4 trial(s) available for ezetimibe and Atrial Fibrillation
| Article | Year |
|---|---|
Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Atrial Function, Left; Azetidines; Blood Flow Velocity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Echocardiography, Doppler; Electrocardiography; Ezetimibe; Female; Heart Atria; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prognosis; Simvastatin; Treatment Outcome | 2013 |
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS study.
Topics: Aged; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Azetidines; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Global Health; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Rest; Simvastatin; Survival Rate; Time Factors | 2015 |
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Atrophy; Azetidines; Biomarkers; Cholesterol; Double-Blind Method; Ezetimibe; Female; Heptanoic Acids; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Pyrroles; Temporal Lobe | 2012 |
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Aortic Valve Stenosis; Atrial Fibrillation; Azetidines; Double-Blind Method; Ezetimibe; Female; Heart Ventricles; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Simvastatin; Stroke; Time Factors; Ultrasonography | 2012 |
2 other study(ies) available for ezetimibe and Atrial Fibrillation
| Article | Year |
|---|---|
Statin versus ezetimibe-statin for incident atrial fibrillation among patients with type 2 diabetes mellitus with acute coronary syndrome and acute ischemic stroke.
Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Diabetes Mellitus, Type 2; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Simvastatin; Stroke; Treatment Outcome | 2023 |
Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy.
Topics: Aged; Amygdala; Anticholesteremic Agents; Atorvastatin; Atrial Fibrillation; Azetidines; Brain; Cognition; Electrocardiography; Executive Function; Ezetimibe; Female; Heptanoic Acids; Hippocampus; Humans; Image Processing, Computer-Assisted; Inflammation; Magnetic Resonance Imaging; Male; Memory; Neuroimaging; Neuropsychological Tests; Psychomotor Performance; Pyrroles; Reaction Time; Vocabulary | 2013 |